We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Industry Insights

Anti-Müllerian Hormone (AMH) and Fertility Assessment content piece image
Industry Insight

Anti-Müllerian Hormone (AMH) and Fertility Assessment

Clinicians have been using AMH in treatments related to reproductive health for over 20 years. High-quality diagnostic assays have come on in leaps and bounds over that time, continuing to provide precise insights to support clinical decisions made in the areas of reproductive aging, fertility and pregnancy monitoring.
NGS During the COVID-19 Pandemic and Beyond content piece image
Industry Insight

NGS During the COVID-19 Pandemic and Beyond

Technology Networks recently spoke with Dr. Nick Downey, NGS collaborations lead at IDT, to learn more about the ways that NGS is being used as part of the response to the pandemic and gain insights into how and why this varies globally.
Overcoming the Challenges of Lentiviral Vector Production content piece image
Industry Insight

Overcoming the Challenges of Lentiviral Vector Production

In this interview, Dr. Koh Meng Yong discusses the advantages of using lentiviral vectors and some of the applications they are enabling.
Scaling Up the Production of Cell Cultured Human Milk  content piece image
Industry Insight

Scaling Up the Production of Cell Cultured Human Milk

To learn how cell cultured human milk is produced and how it compares to mothers’ milk, Technology Networks spoke to Shayne Guiliano, CEO of 108Labs. In this interview, Shayne also highlights the impact that scaling up the technology will have and shares his thoughts on what could be in store for the future of cellular agriculture.
Cancer Research: Potential Key To Unlocking Alzheimer’s Disease Therapies content piece image
Industry Insight

Cancer Research: Potential Key To Unlocking Alzheimer’s Disease Therapies

In the search to discover new therapeutic approaches for AD, scientists are finding new inspiration where others may have never thought to look: cancer research trends.
Accelerating the Commercialization of COVID-19 Neutralizing Antibodies With Plant-Based Manufacturing content piece image
Industry Insight

Accelerating the Commercialization of COVID-19 Neutralizing Antibodies With Plant-Based Manufacturing

The biotechnology company Angany recently announced the successful production of neutralizing monoclonal antibodies (NAbs) derived from the plasma of COVID-19 patients using its plant-based system. Angany has now joined forces with global technology company Phylloceuticals to leverage its plant-made commercial production system, to rapidly scale up commercial manufacturing.
Interview: Behind the E-mmunotherapy Earbud That Could Treat Arthritis content piece image
Industry Insight

Interview: Behind the E-mmunotherapy Earbud That Could Treat Arthritis

Non-invasive stimulation company Nēsos recently announced that its “e-mmunotherapy” earbud has been granted breakthrough device designation by the US Food and Drug Administration (FDA) for patients with rheumatoid arthritis (RA). We spoke to Konstantinos Alataris, president and CEO of Nēsos, to find out more about the company's device and its potential applications.
Diagnostic Biomarkers in Human Primary Membranous Nephropathy: anti-PLA2R, anti-THSD7A and Beyond content piece image
Industry Insight

Diagnostic Biomarkers in Human Primary Membranous Nephropathy: anti-PLA2R, anti-THSD7A and Beyond

In this article, we discuss the role of anti-PLA2R and anti-THSD7A antibodies in the diagnosis of primary membranous nephropathy and highlight why there is a need to measure these biomarkers before kidney transplants.

The Antibody Test That Quantifies COVID-19 Vaccine Protection content piece image
Industry Insight

The Antibody Test That Quantifies COVID-19 Vaccine Protection

Dr Stephen Russell explores how measuring neutralizing antibody levels can help understand how risk levels can change over time and determine optimal vaccine dosing strategies.
Collaboration Between Organizations Is the Key to Getting Ahead of the COVID-19 Pandemic content piece image
Industry Insight

Collaboration Between Organizations Is the Key to Getting Ahead of the COVID-19 Pandemic

Testing for the presence of the SARS-CoV-2 virus continues to be critical across the world, and will be in the future, particularly in light of new variants. The key to expanding and perfecting testing lies, arguably, in effective partnerships between organizations.
Advertisement